Skip to main content
IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.286
+0.000 (0.03%)
Mar 9, 2026, 1:35 PM EDT - Market open

IGC Pharma Revenue

IGC Pharma had revenue of $191.00K in the quarter ending September 30, 2025, a decrease of -53.64%. This brings the company's revenue in the last twelve months to $1.11M, down -6.51% year-over-year. In the fiscal year ending March 31, 2025, IGC Pharma had annual revenue of $1.27M, down -5.50%.

Revenue (ttm)
$1.11M
Revenue Growth
-6.51%
P/S Ratio
24.77
Revenue / Employee
$15,800
Employees
70
Market Cap
27.40M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20251.27M-74.00K-5.50%
Mar 31, 20241.35M434.00K47.64%
Mar 31, 2023911.00K514.00K129.47%
Mar 31, 2022397.00K-501.00K-55.79%
Mar 31, 2021898.00K-3.17M-77.95%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Kyntra Bio 8.30M
Evaxion 7.53M
Cue Biopharma 7.10M
Dyadic International 3.34M
RenovoRx 928.00K
Exicure 500.00K
Hyperion DeFi 345.32K
Revenue Rankings

IGC News

More News